FMP

FMP

Enter

UNCY - Unicycive Therapeuti...

photo-url-https://images.financialmodelingprep.com/symbol/UNCY.png

Unicycive Therapeutics, Inc.

UNCY

NASDAQ

Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.

0.68 USD

0.031 (4.56%)

Valuation Date:

Mar 21, 2025 4:00 PM

Share Price on Valuation Date

$0.68

Stock Beta

2.252

Shares Outstanding

103796000

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2024 © Financial Modeling Prep